Consistent with this, and with the essential function of splicing in eukaryotic biology, mutations in SF3B1 do not lead to widespread changes in the splicing patterns of tumor cells, as assessed with RNA-Seq [24,32,34,35]. This evidence concerns the gene SF3B1 and neoplasm.